Sphingolipid metabolism in the regulation of bioactive molecules

被引:31
作者
Luberto, C [1 ]
Hannun, YA [1 ]
机构
[1] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA
关键词
D O I
10.1007/BF02562221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S5 / S11
页数:7
相关论文
共 62 条
[1]   EVIDENCE AGAINST INVOLVEMENT OF THE ACID LYSOSOMAL SPHINGOMYELINASE IN THE TUMOR-NECROSIS-FACTOR-INDUCED AND INTERLEUKIN-1-INDUCED SPHINGOMYELIN CYCLE AND CELL-PROLIFERATION IN HUMAN FIBROBLASTS [J].
ANDRIEU, N ;
SALVAYRE, R ;
LEVADE, T .
BIOCHEMICAL JOURNAL, 1994, 303 :341-345
[2]   STIMULATION OF ACID CERAMIDASE ACTIVITY BY SAPOSIN-D [J].
AZUMA, N ;
OBRIEN, JS ;
MOSER, HW ;
KISHIMOTO, Y .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 311 (02) :354-357
[3]   PURIFICATION, CHARACTERIZATION, AND BIOSYNTHESIS OF HUMAN ACID CERAMIDASE [J].
BERNARDO, K ;
HURWITZ, R ;
ZENK, T ;
DESNICK, RJ ;
FERLINZ, K ;
SCHUCHMAN, EH ;
SANDHOFF, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11098-11102
[4]   BIOSYNTHESIS OF SPHINGOMYELIN FROM ERYTHRO-CERAMIDES AND PHOSPHATIDYLCHOLINE BY A MICROSOMAL CHOLINEPHOSPHOTRANSFERASE [J].
BERNERT, JT ;
ULLMAN, MD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 666 (01) :99-109
[5]   (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase [J].
Bielawska, A ;
Greenberg, MS ;
Perry, D ;
Jayadev, S ;
Shayman, JA ;
McKay, C ;
Hannun, YA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12646-12654
[6]  
BRADY RO, 1965, J BIOL CHEM, V240, P3693
[7]   APOPTOTIC SIGNALING THROUGH CD95 (FAS/APO-1) ACTIVATES AN ACIDIC SPHINGOMYELINASE [J].
CIFONE, MG ;
DEMARIA, R ;
RONCAIOLI, P ;
RIPPO, MR ;
AZUMA, M ;
LANIER, LL ;
SANTONI, A ;
TESTI, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1547-1552
[8]   RETINOBLASTOMA GENE-PRODUCT AS A DOWNSTREAM TARGET FOR A CERAMIDE-DEPENDENT PATHWAY OF GROWTH ARREST [J].
DBAIBO, GS ;
PUSHKAREVA, MY ;
JAYADEV, S ;
SCHWARZ, JK ;
HOROWITZ, JM ;
OBEID, LM ;
HANNUN, YA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1347-1351
[9]   Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway [J].
Dbaibo, GS ;
Perry, DK ;
Gamard, CJ ;
Platt, R ;
Poirier, GG ;
Obeid, LM ;
Hannun, YA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :481-490
[10]   Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis [J].
DeMaria, R ;
Lenti, L ;
Malisan, F ;
dAgostino, F ;
Tomassini, B ;
Zeuner, A ;
Rippo, MR ;
Testi, R .
SCIENCE, 1997, 277 (5332) :1652-1655